Cognitive Functional Therapy for Chronic Shoulder Pain: Pilot and Feasibility Study

February 17, 2025 updated by: Danilo Harudy Kamonseki, Federal University of Paraíba

Cognitive Functional Therapy Versus Therapeutic Exercises for Treating Individuals With Chronic Shoulder Pain: A Pilot and Feasibility Study

This pilot randomized controlled clinical trial (RCT) will assess the feasibility and identify the key components necessary for conducting the main RCT, which will involve the comparison of Cognitive Functional Therapy with Therapeutic Exercises in individuals with chronic shoulder pain. The main questions it aims to answer are:

  • What barriers to the participation of the included individuals might arise?
  • Will the assessment procedures and outcome measures be feasible and suitable?
  • What time will be necessary to conduct the assessments?
  • Will participants be willing to be randomized to the proposed treatment groups?
  • What barriers to the clinical delivery of Cognitive Functional Therapy in the healthcare system might exist?
  • Will the treatment(s) be acceptable to patients?
  • Will participants adhere to the treatment?
  • What will the recruitment rates be per week/month?
  • Will there be any selection bias?
  • Will participant retention be high among the allocation groups?
  • Will the data be complete?
  • What will the data variability be?
  • Will the treatment effects/outcomes be consistent with expectations and previous literature?

Study Overview

Detailed Description

Shoulder pain is a potentially debilitating musculoskeletal condition, with functional, physical, and psychological impact. Its chronicity has been mainly correlated with affective-emotional and cognitive dimensions of pain. In this scenario, interventions for individuals with chronic shoulder pain should be seen within the biopsychosocial model. In this context, Cognitive Functional Therapy (CFT) emerges as a psychologically informed physiotherapeutic approach directed towards the biopsychosocial and multidimensional nature of pain, which is divided into three approaches to reduce pain and disability: (1) understanding pain, (2) controlled exposure, and (3) lifestyle change. The present study aims to verify the feasibility and viability of a randomized clinical trial to compare the effects of Cognitive Functional Therapy with therapeutic exercises in individuals with chronic shoulder pain.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Paraíba
      • João Pessoa, Paraíba, Brazil, 58051-970
        • Recruiting
        • Federal University of Paraíba
        • Contact:
          • VALÉRIA MA OLIVEIRA, PhD
        • Principal Investigator:
          • VALÉRIA MA OLIVEIRA, PhD
        • Principal Investigator:
          • RAQUEL MC DINIZ, PT
        • Principal Investigator:
          • JÉSSICA MS EUGÊNIO, PT
        • Principal Investigator:
          • DANILO H KAMONSEKI, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Men and women;
  • Age between 18 and 60 years;
  • Presence of shoulder pain for more than 3 months;
  • Pain intensity of 4 points or more on the 11-point Numeric Pain Rating Scale during the past week.
  • High level of disability or moderate level of irritability.

Exclusion Criteria:

  • History of fracture or surgery of the clavicle, scapula, and/or humerus, surgical stabilization or rotator cuff repair;
  • History of dislocation, instability (positive sulcus sign or apprehension test), and/or rotator cuff tear (positive drop arm test);
  • Adhesive capsulitis verified by the presence of gradual onset pain associated with stiffness and reduced passive and active mobility;
  • Ongoing pregnancy;
  • Reproduction of shoulder pain radiating to the entire upper limb during cervical or thoracic spine tests (positive Spurling test);
  • Neurological or systemic diseases that may alter muscle strength and sensitivity such as rheumatoid arthritis, fibromyalgia, lupus, gout, and diabetes;
  • Corticosteroid injection in the shoulder region in the last 3 months;
  • Physiotherapy treatment in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive Functional Therapy
Cognitive Functional Therapy will be conducted once a week, in individual and in-person sessions lasting approximately 40 minutes, over eight weeks.

The intervention focuses on addressing the maladaptive cognitive, physical, and lifestyle behaviors related to the disorder.

Cognitive functional therapy will focus on factors considered to contribute to the pain disorder, addressing the following topics:

  1. The multidimensional nature of persistent pain, beliefs, emotions, and behaviors (movement and lifestyle) that can reinforce a vicious cycle of pain sensitization and disability.
  2. Specific functional training designed to normalize maladaptive and provocative postural and movement behaviors as directed by the individual's presentation.
  3. Targeted functional integration into daily activities that are avoided and/or provocative for the patient.
  4. Counseling on physical activity and lifestyle, which will include promoting a gradual increase in physical activity based on the individual's preference and availability, advice on sleep hygiene, stress management strategies, and social re-engagement
Active Comparator: Exercises
Twelve participants will be allocated to this group. They will perform strengthening and stretching exercises twice a week for eight weeks, with each session lasting approximately 30 to 40 minutes.

Individuals allocated to this group will perform stretching and strengthening exercises. The self-stretching exercises will target the upper trapezius and posterior shoulder region. Each stretching exercise will be performed for 3 repetitions of 30 seconds, with an interval of 10 seconds between repetitions.

The strengthening exercises will be performed using resistance elastic bands. Three sets of 10 repetitions will be performed for each strengthening exercise, with 1 minute of rest between sets. The strengthening exercises will target the lower and middle trapezius, anterior serratus, and the external and internal rotators of the shoulder.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: 8 weeks
Analyze the ability to recruit 12 individuals per group, totaling a sample of 24 individuals with chronic shoulder pain;
8 weeks
Retention rate
Time Frame: 8 weeks
This will be evaluated through individual follow-up by the responsible physiotherapist during the 8-week treatment period, during which the physiotherapist will fill out an attendance sheet at each session to also characterize the completion of the intervention by each participant;
8 weeks
Acceptability of the intervention
Time Frame: 8 weeks
This will be estimated through adherence to the appointment schedule and mainly through questioning after each intervention session.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
The pain will be measured with 11 point - Numerical Rating Pain Scale with scores ranging from 0 (no pain) to 10 (maximum pain).
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Shoulder Pain and Disability Index
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Shoulder disability will be measured with Shoulder Pain and Disability Index (SPADI), with score ranging from 0 to 100, with higher scores indicating greater shoulder disability.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Chronic Pain Self-Efficacy Scale
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Self-efficacy will be measured using the Chronic Pain Self-Efficacy Scale (CPSS). The total score ranges from 30 to 300 points, with higher scores indicating greater self-efficacy.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Tampa Scale for Kinesiophobia
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Kinesiophobia will be measured using the Tampa Scale for Kinesiophobia (TSK). The total score ranges from 17 to 68 points, with higher scores indicating worse beliefs about pain related to movement.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Pain Catastrophizing Scale
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Pain catastrophizing will be measured using the Pain Catastrophizing Scale (PCS). The total score ranges from 0 to 52 points, with higher scores indicating greater pain catastrophizing.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Pittsburgh Sleep Quality Index
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 21 points. A score greater than 5 indicates poor sleep quality, with significant difficulty in at least two components of the questionnaire or moderate difficulty in three components.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Biopsychosocial aspects
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Biopsychosocial aspects will be measured with short screening questions on biopsychosocial aspects of chronic pain.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)
Patients' expectations of the treatment.
Time Frame: Baseline
For the assessment of patients' expectations regarding their treatment, participants will respond to the question, "How much do you expect your shoulder problem to change as a result of treatment?" Their responses will be measured on a 7-point Likert scale, where 1 corresponds to "worse" and 7 corresponds to "completely recovered."
Baseline
Patient-Specific Functional Scale
Time Frame: Pre (baseline), 4 weeks, and post Treatment (8 weeks)
The Patient-Specific Functional Scale (PSFS) will be used to assess functional status. Individuals will score on an 11-point scale, indicating how difficult it is to perform 3 to 5 activities that are important to them. A score of 0 on the 11-point scale indicates "unable to perform the activity," while a score of 10 indicates "able to perform the activity at the pre-injury level.
Pre (baseline), 4 weeks, and post Treatment (8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: VALÉRIA MA OLIVEIRA, PhD, Universidade Federal da Paraíba

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2025

Primary Completion (Estimated)

July 31, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

July 23, 2024

First Submitted That Met QC Criteria

August 5, 2024

First Posted (Actual)

August 7, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 17, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The individual participant data will be shared under request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe